6ED-34175-33754
3 vaccinations
13 coded responses
28 check-ins
13 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 850 / AZ
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Moderna
-
2021-03-25
Registered in v-safe
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
-
2021-04-14
Survey response — day 21, dose 1MedDRA: Back pain, Polymenorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Unusual back pain relating to menstruation, and shorter menstrual period.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Dose 2 — Moderna
-
2021-04-21
Survey response — day 0, dose 2MedDRA: Emotional disorder, Feeling abnormal — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Mental fog and increased emotional sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Affect lability — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased emotional sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Mental fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased, Injection site warmth — Feeling: Good · Site: Redness, SwellingFree text: Elevated temperature around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth — Feeling: Good · Site: Redness, SwellingFree text: Raised temperature in the area surrounding the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth — Feeling: GoodFree text: Raised temperature around injection site, though it's lower than yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth — Feeling: GoodFree text: Increased temperature around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-05-05
- 2021-07-21
-
2021-12-24
Dose 3 — Moderna
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Diarrhea, Abdominal painAdult check-in
- 2021-12-28
-
2021-12-29
Survey response — days 1–6 daily, dose 3MedDRA: Injection site warmth — Feeling: Good · Site: Pain, RednessFree text: Raised temperature around injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — days 1–6 daily, dose 3MedDRA: Injection site warmth — Feeling: Good · Site: RednessFree text: Raised temperature around injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Survey response — day 7, dose 3MedDRA: Injection site warmth — Feeling: Good · Site: RednessFree text: Raised temperature around injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
- 2022-01-14
-
2022-01-21
Survey response — day 28, dose 3MedDRA: Heavy menstrual bleeding, Migraine — Feeling: Poor · Be unable to work or attend schoolFree text: Heavier than usual menstrual cycle, immediately followed by a week-long migraine.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-28
- 2022-02-04
- 2022-03-27
-
2022-06-24
Survey response — 6 months, dose 3MedDRA: Lymph node pain, Lymphadenopathy, Parotid gland enlargement, Salivary gland pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: After my booster, a hyperactive lymph node swelled painfully along with my parotid gland on the side I got my booster on.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-24
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-27
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Moderna | |
| 2 | 2021-04-21 | Moderna | |
| 3 | 2021-12-24 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 7 — day 21, dose 1
Symptoms: Unusual back pain relating to menstruation, and shorter menstrual period.
Release 7 — day 0, dose 2
Systemic reaction (other): Mental fog and increased emotional sensitivity
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Increased emotional sensitivity
Systemic reaction (other): Mental fog
Systemic reaction (other): Elevated temperature around the injection site
Systemic reaction (other): Raised temperature in the area surrounding the injection site
Systemic reaction (other): Raised temperature around injection site, though it's lower than yesterday
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Increased temperature around injection site
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Raised temperature around injection site
Systemic reaction (other): Raised temperature around injection site
Release 10 — day 7, dose 3
Systemic reaction (other): Raised temperature around injection site
Release 10 — day 28, dose 3
Symptoms: Heavier than usual menstrual cycle, immediately followed by a week-long migraine.
Release 12 — 6 months, dose 3
Symptoms: After my booster, a hyperactive lymph node swelled painfully along with my parotid gland on the side I got my booster on.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Lymph node pain | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Parotid gland enlargement | · | · | ✓ |
| SD | Polymenorrhoea | ✓ | ✓ | ✓ |
| SD | Salivary gland pain | · | · | ✓ |
| SRO | Affect lability | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ○ |
| SRO | Emotional disorder | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release